Search bioRxiv⌕ Search

bioRxiv · 10.1101/264234

FGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest

Abstract

ObjectiveExcessive alcohol consumption is a leading cause of global morbidity and mortality. However, knowledge of the biological factors that influence ad libitum alcohol intake may be incomplete. Two large studies recently linked variants in the KLB locus with levels of alcohol intake in humans. KLB encodes {beta}-klotho, co-receptor for the liver-derived hormone fibroblast growth factor 21 (FGF21). In mice, FGF21 reduces alcohol intake, and human Fgf21 variants are enriched among heavy drinkers. Thus, the liver may limit alcohol consumption by secreting FGF21. However, whether full-length, active plasma FGF21 (FGF21 (1-181)) levels in humans increase acutely or sub-chronically in response to alcohol ingestion is uncertain.\n\nMethodsWe recruited 10 healthy, fasted male subjects to receive an oral water or alcohol bolus with concurrent blood sampling for FGF21 (1-181) measurement in plasma. In addition, we measured circulating FGF21 (1-181) levels, liver stiffness, triglyceride, and other metabolic parameters in three healthy Danish men before and after consuming an average of 22.6 beers/person/day (4.4 g/kg/day of ethanol) for three days during Oktoberfest 2017 in Munich, Germany. We further correlated fasting FGF21 (1-181) levels in 49 healthy, non-alcoholic subjects of mixed sex with self-reports of alcohol-related behaviors, emotional responses, and problems. Finally, we characterized the effect of recombinant human FGF21 injection on ad libitum alcohol intake in mice.\n\nResultsWe show that alcohol ingestion (25.3 grams or ~2.5 standard drinks) acutely increases plasma levels of FGF21 (1-181) 3.4-fold in fasting humans. We also find that binge drinking for three days at Oktoberfest is associated with a 2.1-fold increase in baseline FGF21 (1-181) levels, in contrast to minor deteriorations in metabolic and hepatic biomarkers. However, basal FGF21 (1-181) levels were not correlated with differences in alcohol-related behaviors, emotional responses, or problems in our non-alcoholic subjects. Finally, we show that once-daily injection of recombinant human FGF21 reduces ad libitum alcohol intake by 21% in mice.\n\nConclusionsFGF21 (1-181) is markedly increased in circulation by both acute and sub-chronic alcohol intake in humans, and reduces alcohol intake in mice. These observations are consistent with a role for FGF21 as an endocrine inhibitor of alcohol appetite in humans.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Soeberg, S., Andersen, E. S., Dalgaard, N. B., Jarlhelt, I., Hansen, N. L., Hoffmann, N., Vilsboell, T., Chenchar, A., Jensen, M., Grevengoed, T. J., Trammell, S. A. J., Knop, F. K., Gillum, M. P.. 2018-02-13. FGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest. https://doi.org/10.1101/264234

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Leg blood flow and muscle oxygenation are reduced when exercising with loads >=40% 1RM compared to loads <=30% 1RM due to increases in contraction induced intramuscular pressure

The critical occluding tension (COT) is the load at which contraction-induced increases in intramuscular pressure (IMP) collapse intramuscular vasculature and impair oxygen delivery. For knee extension resistance exercise, the COT occurs at ~30-40% 1RM, yet few studies have measured IMP alongside convective oxygen delivery. This study examined the interaction between IMP, leg blood flow, and muscle oxygenation during resistance exercise. Twelve participants completed knee extension bouts across a range of loads while vastus lateralis IMP, femoral blood flow (Doppler), blood pressure, muscle oxygenation (NIRS), and electromyography (EMG) were recorded. Mean IMP increased alongside relative load (20% 1RM=19.1(9.4) mmHg; 30% 1RM=22.4(10.4) mmHg; 40% 1RM=27.0(8.7) mmHg; 50% 1RM=31.5(11.5) mmHg; 60% 1RM=41.14(13.8) mmHg; p<0.05). Leg blood flow scaled to rest was similar between 20% and 30% 1RM (p=0.13), 40%, 50%, and 60% 1RM (p>0.05), but different between the 20-30% 1RM and 40-60% 1RM groupings (p<0.05) (20% 1RM=2.6(1.4) times rest; 30% 1RM=1.8(0.5) fold of rest; 40% 1RM=1.4(0.6) fold of rest; 50% 1RM=1.1(0.4) fold of rest; 60% 1RM=1.1(0.5) fold of rest). Muscle oxygenation was lower at 40%, 50%, and 60% 1RM compared to 20% and 30% 1RM (p<0.05). Thus, at [&le;]30% 1RM exercising blood flow increased well above rest, indicating preserved microvascular perfusion, whereas at [&ge;]40% 1RM the rise in IMP was sufficient to impair perfusion and limit blood flow increases. Exercise at or above the COT restricts convective oxygen delivery due to contraction-induced increases in IMP.

physiology↗

Female biases in islet cell gene expression, alpha cell number, and glucagon are present early in postnatal life

Biological sex significantly affects glucose homeostasis. Sex differences in insulin sensitivity in peripheral tissues play a role in this difference; however, a growing body of evidence suggests sex differences in islet cells also contribute to differential glucose homeostasis. Studies in rodent and human models have identified sex differences in alpha- and beta-cell gene expression, in islet cell composition, metabolism, and stress responses, and in circulating levels of glucoregulatory hormones. However, most of these studies used adult humans or mice, leaving the age at which these differences emerge less clear. We performed a detailed characterization of glucose homeostasis and islet biology in young male and female mice from two mouse strains widely used in diabetes research to model both Type 1 (non-obese diabetic, NOD) and Type 2 diabetes (C57BL/6J). We uncovered male-female differences in islet cell gene expression and composition, and in circulating levels of glucagon. Importantly, these differences were reproducible across both models and were present prior to diabetes-like phenotypes. Together, our data suggest sex differences in aspects of islet biology begin early in postnatal life.

physiology↗

Quantitative imaging of native tissue architecture combined with deep multi-omics reveals the spatial biology of kidney aging

Aging alters tissue architecture and metabolism in spatially heterogeneous ways, yet the connections between these measurable structural and compositional phenotypes and underlying molecular changes are largely unknown. Here, we introduce NORIGAMI (NoRI-Guided AI for Multimodal Integration), a pipeline combining Normalized Raman Imaging (NoRI), deep learning, quantitative morphology, deep proteomics, and metabolomics to investigate renal aging. Unlike conventional histology, NoRI provides label-free, scattering-corrected measurements of absolute total protein and lipid mass concentrations (mg/mL). In 32 male rats aged 9, 18, 21 and 25 months, NORIGAMI predicted the chronological age of held-out rats from NoRI images (mean absolute error 0.78 months; R^2 = 0.97), and whole-tissue images outperformed models trained on isolated tubules. Quantitative imaging identified 41 age-associated morphological and compositional features (FDR < 0.05), revealing anatomically heterogeneous and non-linear changes in lipid droplet concentration, droplet size, cytoplasmic lipid concentration and tubular architecture. Deep molecular profiling quantified 11,485 proteins and 269 metabolites, revealing coordinated declines in differentiated proximal tubule (PT) identity and oxidative metabolism, selective increases in basement-membrane collagen-IV chains, and increasing molecular heterogeneity with age. A protein clock, built mainly from extracellular-matrix and heparan-sulfate proteins, predicted age with a mean absolute error of 1.6 months. Old kidneys diverged along a dominant injury-remodeling axis, seen separately in the proteome, in kidney RNA from 54 other rats and in the metabolome, in which tubular-injury and immune proteins, including the NAD+ consuming enzyme CD38, rise as differentiated-tubule proteins and NAD+ fall. NORIGAMI subsequently linked NAD+ associated molecular changes to quantitative features of tubular geometry and protein-lipid organization, while complementary KIM-1-centered analyses identified overlapping morphological associations involving epithelial injury and lipid handling and yielded additional molecular candidates for mechanistic validation. Collectively, these findings suggest that declining tubular metabolic function, altered lipid organization and injury-associated molecular programs represent interconnected features of renal aging. NORIGAMI establishes a framework for identifying the quantitative structural manifestations of molecular aging and generating spatially informed, experimentally testable hypotheses about tissue dysfunction.

physiology↗